📣 VC round data is live. Check it out!
- Public Comps
- Forian
Forian Valuation Multiples
Discover Forian's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Health In Tech, JLK, Susmed, SMAIO and more.
Forian Overview
About Forian
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
Founded
2014
HQ

Employees
48
Website
Financials (FY)
EV
$36M
Valuation Multiples
Start free trialForian Stock Performance
Forian has current market cap of $68M, and enterprise value of $36M.
Market Cap Evolution
Forian's stock price is $2.17.
Forian share price increased by 10.7% in the last year.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $36M | $68M | 0.0% | - | 4.9% | 10.7% | - |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialForian Valuation Multiples
Forian Financial Valuation Multiples
As of June 3, 2026, Forian has market cap of $68M and EV of $36M.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Forian Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Forian Competitors
Forian competitors include Health In Tech, JLK, Susmed, SMAIO, Research Solutions, ezCaretech, Omda, DocCheck, PharmX Technologies and Mach7 Technologies.
Most Forian public comparables operate across Healthcare Software, B2B SaaS, Vertical SaaS, ViceTech, CannaTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.8x | 1.5x | 14.7x | 45.0x | |||
| 28.0x | - | (8.2x) | - | |||
| 12.7x | 12.7x | (21.8x) | - | |||
| 5.8x | 5.1x | (60.2x) | (63.8x) | |||
| 1.2x | 1.3x | 11.5x | 10.2x | |||
| 1.3x | - | 20.7x | - | |||
| 2.3x | 2.3x | 8.4x | 9.1x | |||
| 0.9x | - | 5.0x | - | |||
This data is available for Pro users. Sign up to see all Forian competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Forian
Forian has acquired 1 company to date.
Last acquisition by Forian was on November 1st 2024. Forian acquired Kyber Data Science for undisclosed valuation.
Latest Acquisitions by Forian
| Description | Kyber Data Science is a New York-based subsidiary of Cowen Inc. that curates proprietary datasets for institutional investors and hedge funds in equities, fixed income, and alternatives. The platform delivers granular data on corporate events, insider transactions, and supply chain metrics, serving clients like Citadel and Millennium Management. Acquired by Cowen in 2020, Kyber processes over 10 million data points daily from public filings, news wires, and satellite imagery to power quantitative trading strategies. Its tools integrate via APIs for seamless workflow embedding in buy-side research platforms. |
| HQ Country | |
| HQ City | New York City, NY |
| Deal Date | 1 Nov 2024 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Forian acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Forian
| When was Forian founded? | Forian was founded in 2014. |
| Where is Forian headquartered? | Forian is headquartered in United States. |
| How many employees does Forian have? | As of today, Forian has over 48 employees. |
| Who is the CEO of Forian? | Forian's CEO is Max C. Wygod. |
| Is Forian publicly listed? | Yes, Forian is a public company listed on Nasdaq. |
| What is the stock symbol of Forian? | Forian trades under FORA ticker. |
| When did Forian go public? | Forian went public in 2021. |
| Who are competitors of Forian? | Forian main competitors include Health In Tech, JLK, Susmed, SMAIO, Research Solutions, ezCaretech, Omda, DocCheck, PharmX Technologies, Mach7 Technologies. |
| What is the current market cap of Forian? | Forian's current market cap is $68M. |
| Is Forian profitable? | No, Forian is not profitable. |
| How many companies Forian has acquired to date? | As of June 2026, Forian has acquired 1 company. |
| What was the largest acquisition by Forian? | None of the M&A deals Forian has completed have disclosed valuations. |
| What companies Forian acquired? | Forian acquired Kyber Data Science. |
| In how many companies Forian has invested to date? | Forian hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Forian
Lists including Forian
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
